Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05165745 · ClinicalTrials.gov registry record · NA

Stick2PrEP Cisgender Women and Trans Individuals

A NA study of HIV Prevention and Pre-exposure Prophylaxis, sponsored by Columbia University.

Recruiting
Registry status
NA
Development phase
175
Enrollment target
1
Study location

NCT05165745 is a NA study of HIV Prevention and Pre-exposure Prophylaxis that is actively recruiting participants, run by Columbia University. The registered enrollment target is 175 participants, below the 376-participant average among 32 other HIV Prevention trials with a reported enrollment target (53% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05165745, a NA study of HIV Prevention and Pre-exposure Prophylaxis, is actively recruiting participants, sponsored by Columbia University.

RECRUITING
Registry status
NA
Development phase
175 participants
Enrollment target
1
Study location

Study Summary

Taking a daily anti-HIV pill can protect people from HIV infection. This is called preexposure prophylaxis \[PrEP\]. Many cisgender women and trans individuals do not know this medication is available; others struggle to take the pill every day. It is important to understand attitudes and preferences about HIV prevention options, especially as new options become available. This study plans to evaluate preferences over time among cisgender women and trans individuals who are taking medication to prevent HIV, and among cisgender women and trans individuals who are not taking medication but are at risk of HIV. The investigators enroll up to 175 participants who visit the HIV prevention clinic, and the investigators will ask participants to complete questionnaires at regular follow up visits and between visits. This study may help the investigators understand how best to prevent HIV among people at risk.

Conditions Studied

HIV Prevention Pre-exposure Prophylaxis

Interventions

  • BEHAVIORAL Individualized Feedback

Study Locations (1)

New York

  • Columbia University Medical Center - New York

Trial Details

FieldValue
Enrollment Target 175 participants
Start Date 2021-10-25
Est. Completion 2026-10-25
Phase NA

Sponsor

Columbia University

958 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05165745

The ClinicalTrials.gov registry entry for NCT05165745 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 175 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 376-participant average among 32 other HIV Prevention trials with a reported enrollment target (53% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with HIV Prevention appearing as the primary indexed condition, and to 1 intervention - of which Individualized Feedback is the first listed.

NCT05165745 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05165745 about?

NCT05165745 is a clinical study titled "Stick2PrEP Cisgender Women and Trans Individuals". Taking a daily anti-HIV pill can protect people from HIV infection. This is called preexposure prophylaxis \[PrEP\]. Many cisgender women and trans individuals do not know this medication is available; others struggle to take the pill every day. It is important to understand attitudes and preference...

What is the current status of trial NCT05165745?

This trial is currently recruiting. It is a NA study. The enrollment target is 175 participants. The study started on 2021-10-25. Estimated completion is 2026-10-25.

What conditions does trial NCT05165745 study?

This clinical trial studies the following conditions: HIV Prevention, Pre-exposure Prophylaxis.

What interventions are being tested in trial NCT05165745?

The interventions under investigation include: Individualized Feedback (BEHAVIORAL).

Who is sponsoring clinical trial NCT05165745?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05165745 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Prevention

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV Prevention

All registered trials for this condition

Pre-exposure Prophylaxis

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.